EGF and ovarian carcinoma: As shown in Figure 3(A), the expression of EGFR had no clear correlation with that of IL-6, but it had a positive correlation with the expression of STAT3 in ovarian cancer (Figure 3(B)).Then, we used epidermal growth factor (EGF) stimulation to activate the EGFR pathway.